Literature DB >> 20207540

Bioisostere of valtrate, anti-HIV principle by inhibition for nuclear export of Rev.

Satoru Tamura1, Nobuhiro Shimizu, Katsuaki Fujiwara, Masafumi Kaneko, Tominori Kimura, Nobutoshi Murakami.   

Abstract

Rational design by the MO calculation disclosed 5,6-dihydrovaltrate (2) as the bioisostere of valtrate (1), the Rev-export inhibitor with anti-HIV activity. The synthesis of 2 was accomplished by ingenious use of asymmetric Diels-Alder reaction and stereoselective epoxidation associated with the adjacent hydroxyl group. Because of similar biological potency to 1, the analog 2 should be recognized as a promising scaffold for new anti-HIV agents with an unprecedented mechanism of action, inhibition for nuclear export of Rev protein, in the conventional remedy. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207540     DOI: 10.1016/j.bmcl.2010.02.038

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

Review 1.  Dynamics of the plant nuclear envelope and nuclear pore.

Authors:  Joanna Boruc; Xiao Zhou; Iris Meier
Journal:  Plant Physiol       Date:  2011-09-26       Impact factor: 8.340

Review 2.  Nuclear export of proteins and drug resistance in cancer.

Authors:  Joel G Turner; Jana Dawson; Daniel M Sullivan
Journal:  Biochem Pharmacol       Date:  2011-12-20       Impact factor: 5.858

Review 3.  Pharmacological inhibition of feline immunodeficiency virus (FIV).

Authors:  Hakimeh Mohammadi; Dorothee Bienzle
Journal:  Viruses       Date:  2012-04-27       Impact factor: 5.048

4.  Studies of the structure-antioxidant activity relationships and antioxidant activity mechanism of iridoid valepotriates and their degradation products.

Authors:  Feifei Wang; Yumei Zhang; Shouhai Wu; Yi He; Zhong Dai; Shuangcheng Ma; Bin Liu
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

Review 5.  CRM1 Inhibitors for Antiviral Therapy.

Authors:  Cynthia Mathew; Reena Ghildyal
Journal:  Front Microbiol       Date:  2017-06-28       Impact factor: 5.640

Review 6.  Inhibiting cancer cell hallmark features through nuclear export inhibition.

Authors:  Qingxiang Sun; Xueqin Chen; Qiao Zhou; Ezra Burstein; Shengyong Yang; Da Jia
Journal:  Signal Transduct Target Ther       Date:  2016-07-01

Review 7.  Controlling the Gatekeeper: Therapeutic Targeting of Nuclear Transport.

Authors:  Friederike K Kosyna; Reinhard Depping
Journal:  Cells       Date:  2018-11-21       Impact factor: 6.600

Review 8.  Structural Basis of Targeting the Exportin CRM1 in Cancer.

Authors:  Achim Dickmanns; Thomas Monecke; Ralf Ficner
Journal:  Cells       Date:  2015-09-21       Impact factor: 6.600

9.  Chickpea transcription factor CaTLP1 interacts with protein kinases, modulates ROS accumulation and promotes ABA-mediated stomatal closure.

Authors:  Vijay Wardhan; Aarti Pandey; Subhra Chakraborty; Niranjan Chakraborty
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.